Evaluation of an intranasal virosomal vaccine against respiratory syncytial virus in mice: effect of TLR2 and NOD2 ligands on induction of systemic and mucosal immune responses (Q34674831)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Evaluation of an intranasal virosomal vaccine against respiratory syncytial virus in mice: effect of TLR2 and NOD2 ligands on induction of systemic and mucosal immune responses	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Evaluation of an intranasal virosomal vaccine against respiratory syncytial virus in mice: effect of TLR2 and NOD2 ligands on induction of systemic and mucosal immune responses (English)

1 reference

Europe PubMed Central

3 August 2017

toll-like receptor

0 references

3

object named as

Jan Wilschut

1 reference

Europe PubMed Central

3 August 2017

Tjarko Meijerhof

2

object named as

Tjarko Meijerhof

1 reference

Europe PubMed Central

3 August 2017

author name string

Muhammad Shafique

1

1 reference

Europe PubMed Central

3 August 2017

Aalzen de Haan

4

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

8 April 2013

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

8

1 reference

Europe PubMed Central

3 August 2017

4

1 reference

Europe PubMed Central

3 August 2017

e61287

1 reference

Europe PubMed Central

3 August 2017

copyright license

Creative Commons Attribution 4.0 International

8 April 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Defending the mucosa: adjuvant and carrier formulations for mucosal immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Innate immunity in the respiratory epithelium.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Effects of NOD-like receptors in human B lymphocytes and crosstalk between NOD1/NOD2 and Toll-like receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

The synthetic bacterial lipopeptide Pam3CSK4 modulates respiratory syncytial virus infection independent of TLR activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Targeting Toll-like receptors: emerging therapeutics?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

TLR2 activation by proteosomes promotes uptake of particulate vaccines at mucosal surfaces

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Immunopathology of RSV infection: prospects for developing vaccines without this complication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

The virosome concept for influenza vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Vaccination strategies for mucosal immune responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Vaccine delivery: lipid-based delivery systems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Effect of MDP-Lys(L18) as a mucosal immunoadjuvant on protection of mucosal infections by Sendai virus and rotavirus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Mucosal and systemic immune responses in BALB/c mice to Bacteroides gingivalis fimbriae administered orally

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Immunity to and frequency of reinfection with respiratory syncytial virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

7 July 2018

Nasal vaccination induces protective immunity without immunopathology.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061287

21 January 2018

Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061287

21 January 2018

The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061287

21 January 2018

Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061287

21 January 2018

Nod2-dependent Th2 polarization of antigen-specific immunity.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061287

21 January 2018

Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061287

21 January 2018

Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061287

21 January 2018

Risk factors for severe respiratory syncytial virus infection in elderly persons

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061287

21 January 2018

Toll-like receptor 2 induces mucosal homing receptor expression and IgA production by human B cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620164

26 October 2018

Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23593453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of IgE responses. V. Oral administration of a synthetic derivative of the inner bacterial cell wall (SDZ 280.636) to sensitized mice induces isotype specific suppression of peak hapten specific IgE antibody forming cell responses, serum IgE

1 reference

https://pubmed.ncbi.nlm.nih.gov/23593453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in h

1 reference

https://pubmed.ncbi.nlm.nih.gov/23593453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MF59 and Pam3CSK4 Boost Adaptive Responses to Influenza Subunit Vaccine through an IFN Type I-Independent Mechanism of Action

1 reference

https://pubmed.ncbi.nlm.nih.gov/23593453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transcriptional analysis of Toll-like receptors expression in M cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23593453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Zymosan enhances the mucosal adjuvant activity of poly(I:C) in a nasal influenza vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/23593453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0061287

1 reference

Europe PubMed Central

3 August 2017

2013PLoSO...861287S

0 references

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34674831&oldid=1865087713"